Press Releases
Philogen announces Philochem Patent Upheld
Philogen announces that Philochem’s European Patent 3083957 relating to important features of proprietary DNA-encoded chemical libraries (“ESAC 2+1” technology) was upheld after Oral Proceedings in front of the Opposition Division...
Read morePhilogen announces R&D program update for Dekavil
Philogen S.p.A. announces an update on the worldwide license agreement with Pfizer to develop Dekavil, a novel investigational therapy for the treatment of autoimmune diseases.
Philogen S.p.A. announces its Half Year 2021 Results on Tuesday 28th September 2021
Philogen to hold a Webinar on Wednesday 29th of September 2021 at 12:00 ET / 17:00 BST / 18:00 CEST (Please find the link to this Webinar here) Download pdf...
Read moreUpcoming Events
Philogen to Participate at the 2021 Virtual Stifel Healthcare Conference on November 15-17, 2021
Stifel Conference provides an opportunity for investors to get a perspective of Philogen progresses and to meet CEO Dario Neri through a series of one-on-one meetings. Co-founder, CEO and CSO, Prof....
Read morePhilogen to attend the Antibody Engineering & Therapeutics on December 12-16 , 2021
Dario Neri, co-founder, CEO and CSO, is giving a presentation focused on Tripokin, a novel fusion protein capable of an exceptionally selective uptake at the tumor site. The product contains...
Read morePhilogen to attend the Cytokine-Based Cancer Immunotherapies Summit on November 30-December 2 , 2021
Dario Neri, co-founder, CEO and CSO, is giving a presentation to address the question on how to achieve the therapeutic dose at the tumor site with cytokine-based targeted products. Roberto...
Read morePast Events
Philogen to participate at the Goldman Sachs Eleventh Annual Biotech Symposium on September 7, 2021
Philogen has been invited to participate at the Eleventh Annual Biotech Symposium organised by Goldman Sachs on September 7, 2021. The aim of the Symposium is to provide an opportunity for investors to get a broader...
Read morePhilogen to Participate at the KBC Life Sciences Conference on September 7-9, 2021
Philogen has been invited to the Life Sciences Conference organised by KBC on September 7-9, 2021. The Conference provides an opportunity for investors to get a perspective of current opportunities and...
Read more